Xiaoxin Chen
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Biological and pharmacological studies of plants
Papers in
-
- Inflammatory mediators and NSAID effects 4
-
- Medical Research and Treatments 2
- Co-authors
- Chung Shu Yang (5 shared papers)Zheng Sun (3 shared papers)Ning Li (2 shared papers)Fengde Chen (1 shared paper)Peng Wang (2 shared papers)Flordeliza Y. Bondoc (1 shared paper)Guang‐Yu Yang (1 shared paper)Stephen K. Curtis (1 shared paper)
- Journals
- Frontiers in Pharmacology (3 papers)Clinical Cancer Research (2 papers)Carcinogenesis (2 papers)Medicine (2 papers)Pharmaceuticals (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaoxin Chen
45 papers receiving 1.1k citations
Xiaoxin Chen's Hit Papers
Peers
Comparison fields: 5 of 98
- Pharmacology 198
- Drug Discovery 2
- Complementary and alternative medicine 51
- Biochemistry 34
- Otorhinolaryngology 26
Countries citing papers authored by Xiaoxin Chen
This map shows the geographic impact of Xiaoxin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxin Chen more than expected).
Fields of papers citing papers by Xiaoxin Chen
This network shows the impact of papers produced by Xiaoxin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxin Chen. The network helps show where Xiaoxin Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoxin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 111 | |
| 2 | 2005 | 110 | |
| 3 | 2004 | 90 | |
| 4 | 2012 | 87 | |
| 5 | 2019 | 83 | |
| 6 | 2002 | 68 | |
| 7 | 2003 | 66 | |
| 8 | 2006 | 63 | |
| 9 | Preclinical evaluation of the SARS-CoV-2 Mpro inhibitor RAY1216 shows improved pharmacokinetics compared with nirmatrelvir Hit paper breakdown → | 2024 | 54 |
| 10 | 2018 | 53 | |
| 11 | 2018 | 37 | |
| 12 | 2005 | 26 | |
| 13 | 2016 | 26 | |
| 14 | 2014 | 24 | |
| 15 | 2013 | 20 | |
| 16 | 2020 | 20 | |
| 17 | 2021 | 19 | |
| 18 | 2023 | 18 | |
| 19 | Inhibitory effects of Zengshengping fractions on DMBA-induced buccal pouch carcinogenesis in hamsters. | 2012 | 16 |
| 20 | 2023 | 16 |
About Xiaoxin Chen
Xiaoxin Chen is a scholar working on Pharmacology, Complementary and alternative medicine, Epidemiology, Surgery and Reproductive Medicine, having authored 51 papers that have together received 1.2k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Cervical and Thoracic Myelopathy (3 papers), Pharmaceutical studies and practices (3 papers), Endometriosis Research and Treatment (3 papers), Phytochemicals and Antioxidant Activities (2 papers), Medical Research and Treatments (2 papers) and EFL/ESL Teaching and Learning (2 papers). The work is most often cited by research in Pharmacology (198 citations), Drug Discovery (2 citations), Complementary and alternative medicine (51 citations), Biochemistry (34 citations) and Otorhinolaryngology (26 citations). Xiaoxin Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Chung Shu Yang, Zheng Sun, Ning Li, Fengde Chen, Peng Wang, Flordeliza Y. Bondoc, Guang‐Yu Yang, Stephen K. Curtis, Su Wang and Mingzhu Fang. Their work appears in journals such as Frontiers in Pharmacology, Clinical Cancer Research, Carcinogenesis, Medicine and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.